Verastem, Inc. (VSTM): Price and Financial Metrics
VSTM Price/Volume Stats
| Current price | $6.43 | 52-week high | $9.10 |
| Prev. close | $6.18 | 52-week low | $2.10 |
| Day low | $6.18 | Volume | 1,202,116 |
| Day high | $6.62 | Avg. volume | 1,404,524 |
| 50-day MA | $6.61 | Dividend yield | N/A |
| 200-day MA | $5.03 | Market Cap | 353.32M |
VSTM Stock Price Chart Interactive Chart >
Verastem, Inc. (VSTM) Company Bio
Verastem, Inc. focuses on discovering and developing drugs for the treatment of cancer. Its programs target the focal adhesion kinase (FAK) and the phosphoinositide 3-kinase (PI3K)/mTOR signaling pathways. The company was founded in 2010 and is based in Needham, Massachusetts.
VSTM Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
VSTM Price Returns
| 1-mo | -3.89% |
| 3-mo | -8.14% |
| 6-mo | 13.81% |
| 1-year | 76.65% |
| 3-year | -60.46% |
| 5-year | -71.50% |
| YTD | 24.37% |
| 2024 | -36.49% |
| 2023 | 68.53% |
| 2022 | -80.37% |
| 2021 | -3.76% |
| 2020 | 58.96% |